IA
CVS icon

IFG Advisors’s CVS Health CVS Stock Holding History

IFG Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,541
Closed -$203K – 136
2024
Q1 		$203K Buy
2,541
+3
+0.1% +$229 0.05% 126
2023
Q4 		$200K Buy
+2,538
New +$181K 0.06% 121
2023
Q1 		– Sell
-2,570
Closed -$239K – 121
2022
Q4 		$239K Sell
2,570
-97
-4% -$9.36K 0.1% 103
2022
Q3 		$254K Buy
2,667
+102
+4% +$10.1K 0.13% 87
2022
Q2 		$238K Sell
2,565
-8
-0.3% -$781 0.12% 93
2022
Q1 		$260K Buy
2,573
+66
+3% +$6.93K 0.11% 93
2021
Q4 		$259K Buy
2,507
+2
+0.1% +$185 0.11% 90
2021
Q3 		$213K Buy
2,505
+2
+0.1% +$168 0.1% 99
2021
Q2 		$209K Buy
+2,503
New +$205K 0.1% 96

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

IFG Advisors's CVS Position: Q2 2024 in Review

IFG Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,541 shares — an estimated $203K sold.

IFG Advisors first reported a position in CVS in Q2 2021 and held it in 9 quarters. The position peaked at $260K in Q1 2022. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • IFG Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • IFG Advisors sold 2,541 CVS Health shares in Q2 2024, an estimated $203K.
  • IFG Advisors first reported a position in CVS Health in Q2 2021 and held it in 9 quarters.
  • IFG Advisors's CVS Health position peaked at $260K in Q1 2022.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on IFG Advisors's 13F filing for Q2 2024, filed 22 Jul 2024.